Technical Analysis for BIB - ProShares Ultra Nasdaq Biotechnology
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
72.67 | -0.57% | -0.42 |
BIB closed down 0.57 percent on Wednesday, August 5, 2020, on 40 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Flat | Down |
| Historical BIB trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Support | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | -0.57% | |
| 50 DMA Support | Bullish | -0.57% | |
| NR7 | Range Contraction | -0.57% | |
| Crossed Above 50 DMA | Bullish | -2.10% | |
| Stochastic Buy Signal | Bullish | -2.10% | |
| Oversold Stochastic | Weakness | -2.10% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Exchange Traded Fund ETF Exchange Traded Funds Stock Market Index Biotechnology Leveraged ETF Ultra ETF Nasdaq Nasdaq 100 Nasdaq Biotechnology Total Return Index
Exchange Traded Fund ETF Exchange Traded Funds Stock Market Index Biotechnology Leveraged ETF Ultra ETF Nasdaq Nasdaq 100 Nasdaq Biotechnology Total Return Index
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 83.06 |
| 52 Week Low | 35.49 |
| Average Volume | 318,876 |
| 200-Day Moving Average | 60.89 |
| 50-Day Moving Average | 72.46 |
| 20-Day Moving Average | 75.37 |
| 10-Day Moving Average | 73.11 |
| Average True Range | 3.44 |
| ADX | 14.3 |
| +DI | 19.61 |
| -DI | 24.31 |
| Chandelier Exit (Long, 3 ATRs ) | 72.74 |
| Chandelier Exit (Short, 3 ATRs ) | 78.29 |
| Upper Bollinger Band | 81.54 |
| Lower Bollinger Band | 69.21 |
| Percent B (%b) | 0.28 |
| BandWidth | 16.36 |
| MACD Line | -0.13 |
| MACD Signal Line | 0.56 |
| MACD Histogram | -0.6895 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 75.69 | ||||
| Resistance 3 (R3) | 75.83 | 74.96 | 75.18 | ||
| Resistance 2 (R2) | 74.96 | 74.20 | 74.89 | 75.01 | |
| Resistance 1 (R1) | 73.82 | 73.72 | 73.39 | 73.68 | 74.85 |
| Pivot Point | 72.95 | 72.95 | 72.74 | 72.88 | 72.95 |
| Support 1 (S1) | 71.81 | 72.19 | 71.38 | 71.67 | 70.49 |
| Support 2 (S2) | 70.94 | 71.71 | 70.87 | 70.33 | |
| Support 3 (S3) | 69.80 | 70.94 | 70.16 | ||
| Support 4 (S4) | 69.66 |
